FibroGen jobs and careers
San Francisco, CA, United States
About FibroGen
FibroGen, Inc. is a science-based biopharmaceutical company discovering and developing a pipeline of first- in-class therapeutics. The Company is focused on fibrosis and hypoxia-inducible factor (HIF) biology and clinical development to advance innovative medicines for the treatment of anemia, fibrotic disease, and cancer. Roxadustat, the Company's most advanced product candidate, is an oral small molecule inhibitor of HIF prolyl hydroxylase activity in Phase III clinical development for the treatment of anemia in chronic kidney disease (CKD), and is entering Phase III development for anemia in lower risk myelodysplastic syndromes (MDS). The Company has developed Pamrevlumab. Pamrevlumab is a proprietary therapeutic antibody to inhibit the activity of connective tissue growth factor (CTGF), a common factor in chronic fibrotic and proliferative disorders characterized by persistent and excessive scarring that can lead to organ dysfunction and failure.
Founded in 1993 by Rory Riggs and Thomas Neff.
- Founded
- 1993
- Employees
- 501 to 1,000
- Total funding
- $308M
- Headquarters
- San Francisco
Leadership
The top of FibroGen's org chart, with how many people report into each leader.
Mark Lonergan
Vice President, Manufacturing And Supply Operations
11 reports
Elias Kouchakji
SVP, Clinical Development, Drug Safety, and Pharmacovigilance
10 reports
Percy H. Carter
Chief Scientific Officer
4 reports
Pat Cotroneo
Executive Advisor To Chief Executive Officer
4 reports
Tricia Stewart
Chief People Officer
4 reports
Carol Gaddum
Executive Director, Product Team Lead
3 reports
Michael D. Lowenstein
Chief Legal Officer
3 reports
Faeq Mansour
Senior Director, Head Of IT
2 reports
Lori S.
Executive Medical Director, Clinical Development
1 report
Thane Wettig
Chief Executive Officer
1 report
Dana Fong
Director, IT Business Integrations
1 report
Leanne C. Price
Chief Intellectual Property Officer
1 report
Chris Newman
Executive Director Business Development
1 report
Christine L. Chung
SVP, China Operations
Dr. Olga V. Gambetti M.D., Ph.D., Drmedsci
Medical Director, Clinical Development
Aileen Huang (Cuihua)
Sr. Medical Manager
Claudia Witschi
Executive Director, Head Analytical Development And Drug Product
Elena Vaisberg
Associate Scientist
Dongxia Li
Principal Scientist
Robin Matthew M.D., Mha, Jd (expected)
Medical Writer (regulatory Affairs)
Gerardo Pangilinan Ms, Dabt
Principal Scientist
Guangjie Guo
Senior Scientist
Gihani Wijewickrama
Principal Scientist CMC Analytical Development In Biologics
Jung Min Park
Sr Scientist
Zhao Hongda
Scientist
Bernardo Lomongsod
Associate Scientist 1
Jack Li
Sr Director Biostatistics
Dennis Kim
Associate Director, IT Operations
Max
IT Manager
Van Pell Gerard
IT Operations Manager
Ginny Kosor
Executive Director Of Facilities Operations
3 reports
Lauren Kury
Director Supply Chain Planning / Roxadustat CMC Team Lead
1 report
Sean Healy
VP Quality
1 report
Sabrina Deng
Head of sourcing and procurement
William Su
Senior Manager, Commercial Supply Chain
Arlene de Vera
Mananger Contract Mfg
Mairead Carney
Executive Director, Head Of Clinical Operations
2 reports
Melissa Meteyry
Drug Development Assistant
Jobs at FibroGen
No open positions right now. Explore more companies on TheJobsMap.